CClinicalTrials.gg
RecruitingNCT03846375Updated Aug 28, 2019

Emotional Dysregulation in Para-suicidal Behavior

An interventional study of Psychotherapy and Pre-intervention testing in Self Harm, Suicide, Attempted and Emotional Instability, sponsored by Haukeland University Hospital. Recruiting at 1 site in Norway. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-28.

Sponsored by Haukeland University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started Jan 2019; still recruiting 7 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This is a naturalistic cohort pre-post study investigating aspects of emotional processing and how possible changes in emotional processing is related to the successful treatment of non-suicidal self-injury and suicidal ideation in a program of Dialectical Behavior Therapy. In addition we wish to identify to what extent the intensity and frequency of non-suicidal self-injury and suicidal ideation is related to difficulty in emotion regulation, as indicated by self-report measures and psychophysiological measures.

Read the detailed description

This naturalistic pre-port study tests if Dialectical Behavior Therapy (DBT) - an established therapy addressing emotion regulation and reduction of non-suicidal self-injury and suicidal ideation - result in increased emotion regulation capacity, indicated by lowered heart rate variability (HRV) and self-report measures. The study will also test the impact of DBT on lowered non-suicidal self-injury and suicidal ideation. Standard Clinical symptom scales will be included in order to control for anxiety, depression, as well as a measure of impulsivity, which is common co-morbidities.

Since DBT was developed in the 80ies, DBT has gathered increased empirical support as a treatment that reduce suicidality, para-suicidal behavior, experienced and expressed anger, and increased social skills. In DBT, emotional dysregulation is assumed to arise from a combination of biological vulnerability and living in an invalidating environment.

Self-harm and chronic suicidality is considered to be an emotion regulation strategy. In DBT, the ability to regulate emotions adaptively requires a set of skills; the ability to experience emotions, the ability to label emotions, and the ability to modulate stimuli that serve to reactivate negative or positive emotions. In the absence of these skills, or instances where the individual is hindered from applying them, more maladaptive behavior is learned and applied. Individuals that engage in non-suicidal self-injury often report greater emotion dysregulation than those without an non-suicidal self-injury history. Such behavior can e.g. be self-inflicted harm, cutting, burning, or hitting , and/or suicidal ideation. Non-suicidal self-injury is viewed as a learned emotion regulation strategy; because such behavior instantly can decrease the experience of negative affect. Therapies that focus on increasing adaptive emotion regulations skills have demonstrated reduced non-suicidal self-injury and suicidal ideation.

The physiological manifestations of emotions rely on an activation of the Autonomic Nervous System. The individual experience of emotions is reciprocally related to the continuously changing levels of physiological arousal. The functioning of this system is in turn related to adapting to environmental demands. A well established measure of Autonomic Nervous activity is variation in inter-beat-intervals due to respiratory influence on heart rate, i.e. respiratory sinus arrhythmia, which is predominately a parasympathetic related innervation of the heart. Hence, HRV is considered a psychophysiological index of emotion regulation abilities. HRV is considered an index of the nervous system's ability to flexibly adapt to changing environmental demands and is considered a biological index of emotion regulation.

We include a matched control sample of healthy controls to complete the battery of measurements at baseline assessment of emotion regulation functions (pre-intervention assessments). This will give the opportunity to characterize the group of patients with non-suicidal self-injury and suicidal ideation included in the current planned study in relation to previous research findings of the same functions in samples of patients with non-suicidal self-injury and suicidal ideation. The combination of clinical, cognitive and psychophysiological measures is a unique feature of this study, and will provide new information regarding the mechanisms underpinning clinical change following DBT, and possibly validate heart rate variability as a possible psychophysiological outcome measure for studies on treatment for non-suicidal self-injury and suicidal ideation.

Statistical analyses Multilevel between-group analyses will be conducted to test for the between-group effects on the measures at baseline. Furthermore, a multiple regression analyses, so that dimensional variables can be included as independent variables in the model, for the pre and post measures. Regression analyses also allow for adjusting for the effects of possible confounders on the outcome measures, such as age, sex, and intensity of depressive symptoms. Furthermore, bootstrapping analysis will be conducted to examine moderator and mediator effects on the outcome measures. Interpretation of the strength of experimental effects will be guided by the use of effect size statistics. Baseline measures of demographics, life experiences, and symptoms may also be used to predict outcomes or as covariates in our analyses.

02

Conditions studied

  • Self Harm
  • Suicide, Attempted
  • Emotional Instability
  • Borderline Personality Disorder

Keywords

  • Emotional Dysregulation
  • Emotional regulation
  • Dialectical Behavioral Therapy
  • para-suicidal behavior
03

In context

Suicide

701 studies on the registry are indexed under Suicide; 183 are open to participants now.

This study's planned enrollment of 60 is below the median of 104 across 560 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

Haukeland University Hospital is the lead sponsor of 276 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria Patients:

  • Patients with non-suicidal self-injury and/or suicidal ideation that undergo standard clinical outpatient DBT treatment will be recruited.

Exclusion Criteria Patients:

  • Lack of informed consent

Exclusion Criteria Healthy Controls:

  • Lack of informed consent
  • former or current neurological conditions
  • severe psychiatric illness
  • cardiac conditions.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Participants in DBT

    Psychotherapy: The participants will be given standard DBT treatment.

    Behavioral: Psychotherapy · Other: Pre-intervention testing

  • Other
    Control Group

    Control Group at preintervention.

    Other: Pre-intervention testing

Interventions

  • BehavioralPsychotherapy

    DBT is a well-established treatment for recurrent self-harm and suicidal thoughts. The program is principle-based, but the skills training follow a manualized curriculum.

  • OtherPre-intervention testing

    Pre-intervention testing for baseline measures.

06

What researchers measure

Primary outcomes

  1. Change in intensity of Suicidal thoughts.

    Intensity of suicidal thoughts on a likert scale from 0 - 5 the last week.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  2. Change in frequency of suicidal thoughts.

    Frequency of suicidal thoughts, that is the number of suicidal thoughts the last week.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  3. Change in frequency of non-suicidal self-injury.

    The frequency of non-suicidal self-injury the last week.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  4. Change in the intensity of impulse to non-suicidal self-injury.

    The intensity in the impulse to non-suicidal self-injury on a likert scale from 0 - 5, the last week.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  5. Change in Heart rate variability .

    Heart rate variability is considered an index of the nervous system's ability to flexibly adapt to changing environmental demands and is considered a biological index of emotion regulation.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  6. Change in self reported emotion regulation ability through Difficulties in Emotion Regulation Scale.

    It is a 36 item questionnaire designed for measuring six facets of difficulties in emotion regulation. The response is give in the from of a rating of 5 point likert scale from 1 ("almost never" to 5 ("almost always). Total score range: 36- 180. It includes the following sub-scales: 1. Nonacceptance of emotional responses, 2. Difficulties engaging in goal directed behavior, 3. Impulse control difficulties, 4. Lack of emotional awareness, 5. Limited access to emotion regulation strategies, 6. Lack of emotional clarity.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

Secondary outcomes

  1. Change in self reported ability to be mindful through the Five Facet Mindfulness Questionnaire.

    The Five Facet Mindfulness Questionnaire is a 39-item self-report questionnaire that assesses various components of mindfulness. Each item is rated on a 1 to 5 scale with 1=never or very rarely true and 5=very often or always true; responses are summed and then divided by 39 (the number of items). The higher score represents a more mindful attitude in daily life.The total score is a aggregate of the following sub-scales: (1) "observe" (the ability to ve aware of the surroundings and inner experiences, (2) describe (the ability to describe inner experiences, (3) act aware ( being aware and present, (4) non-judge (ability to experience with acceptance, and (5) non-react (being non-reactive excessively to inner experience).

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  2. Change in self reported self-compassion through the Self-compassion Scale.

    The Self-compassion Scale questionnaire consists of 26 items. Items are rated on a five-point Likert-type scale from 1 ("almost never") to 5 ("almost always"). Highest possible score is 130. High score indicate ability to be self-compassionate.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  3. Change in ability to experience and verbalise emotions through Toronto Alexithymia Scale 20.

    The Toronto Alexithymia Scale 20 is a 20-item self-report questionnaire consisting of three sub-scales; 1) Difficulty Identifying feelings, 2) Difficulty Describing Feelings, and 3) Externally-oriented Thinking. The full scale range is 20-100, higher scores indicate higher problems in experiencing and verbalizing emotions, i.g. alexithymia. Subscales are summed to compute a total score Scores between 52 and 60 indicate moderate alexithymia; scores 61 and higher indicate high alexithymia.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  4. Change in anxiety symptoms through the Beck Anxiety Inventory.

    The Beck Anxiety Inventory is a 21-item self-report inventory that measures level of anxiety during the past week. Answer being scored on a scale value of 0 (not at all) to 3 (severely). Above 30 indicate severe anxiety, below 21 indication of low og no anxiety.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  5. Change in depressive symptoms through the Beck Depression Inventory.

    Beck Depression Inventory is a 21-item self-report inventory that measures level of depression and is a widely applied measure of depression. Highest possible score is 64. Above 25 indicates severe depressive symptoms, below 9 no depressive symptoms.

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

  6. Change in impulsivity through The Barratt Impulsiveness Scale.

    The Barratt Impulsiveness Scale is a questionnaire designed to assess the personality / behavioral construct of impulsiveness is composed of 30 items describing common impulsive or non-impulsive (for reversed scored items) behaviors and preferences .

    Time frame: Time points will be baseline, week 16, week 32 and at completion of the DBT program, an average of 1 year.

Other outcomes

  1. International Neuropsychiatric Interview.

    The International Neuropsychiatric Interview is a semi-structured diagnostic interview is a structured interview to evaluate the presence of current psychiatric disorders in children, based on 10th revision of the International Statistical Classification of Diseases and Related Health Problems and Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V). The results will be combined to one binary total score 0 (no disorder) and 1 (current disorder).

    Time frame: Time points will be baseline and at completion of the DBT program, an average of 1 year.

  2. Change in the presence of personality disorders through the Structured Clinical Interview for DSM-IV Axis II.

    A semi-structured diagnostic interview used to assess personality disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). The interview covers all ten DSM-IV personality disorders (antisocial, avoidant, borderline, dependent, histrionic, narcissistic, obsessive-compulsive, paranoid, schizoid and schizotypal), personality disorder not otherwise specified, and is used to make personality disorder diagnoses either dimensionally or categorically (present-absent). The instrument will applied dimensionally with scores ranging from 0 to 9. Higher score indicate the presence of personality traits.

    Time frame: Time points will be baseline and at completion of the DBT program, an average of 1 year.

  3. Change in every day functioning through the Global Assessment of Functioning.

    Global Assessment of Functioning is a numeric scale used to rate subjectively the social, occupational, and psychological functioning of an individual his or her day-to-day life on a scale of 0 to 100. High score indicate high functioning.

    Time frame: Time points will be baseline and at completion of the DBT program, an average of 1 year.

07

Study locations

1 of 1 sites recruiting
  • Haukeland University Hospital, Bjørgvin DPS
    Bergen, 5009, Norway
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03846375
Lead sponsor
Haukeland University Hospital
Collaborators
University of Bergen
Responsible party
Sponsor
First posted
Feb 19, 2019
Start date
Jan 15, 2019
Primary completion
Jan 2, 2025 (estimated)
Completion
Jan 2, 2028 (estimated)
Last update
Aug 28, 2019

Study contacts

Berge Osnes, PhD
Contact
berge.osnes@uib.no
+4792445081
Lin Sørensen, PhD
Contact
lin.sorensen@uib.no
Berge Osnes, PhD
principal investigator · Haukeland University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion